E. Alemao

2.0k total citations
118 papers, 1.5k citations indexed

About

E. Alemao is a scholar working on Rheumatology, Surgery and Economics and Econometrics. According to data from OpenAlex, E. Alemao has authored 118 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Rheumatology, 32 papers in Surgery and 29 papers in Economics and Econometrics. Recurrent topics in E. Alemao's work include Rheumatoid Arthritis Research and Therapies (45 papers), Lipoproteins and Cardiovascular Health (27 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). E. Alemao is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (45 papers), Lipoproteins and Cardiovascular Health (27 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). E. Alemao collaborates with scholars based in United States, Sweden and United Kingdom. E. Alemao's co-authors include Glenn Davies, Donald Yin, J.R. Cook, A. Lawrence Gould, D. Yin, G Nocea, Seán Connolly, Éric Van Ganse, Laurent Laforest and Michael E. Weinblatt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

E. Alemao

112 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Alemao United States	23	517	486	373	338	168	118	1.5k
Sumesh Kachroo United States	22	183 0.4×	284 0.6×	161 0.4×	147 0.4×	241 1.4×	91	1.4k
Geert J. M. Boerma Netherlands	7	677 1.3×	211 0.4×	97 0.3×	310 0.9×	259 1.5×	8	1.2k
Gudrun Nyberg Sweden	25	910 1.8×	145 0.3×	174 0.5×	303 0.9×	179 1.1×	56	2.2k
Werner Kleophas Germany	19	394 0.8×	125 0.3×	80 0.2×	148 0.4×	173 1.0×	46	1.2k
Miłosz Jankowski Poland	18	417 0.8×	424 0.9×	86 0.2×	71 0.2×	416 2.5×	50	1.5k
Lisa Nessel United States	15	329 0.6×	162 0.3×	106 0.3×	127 0.4×	373 2.2×	20	2.5k
Lucía Cea Soriano Spain	24	628 1.2×	258 0.5×	61 0.2×	550 1.6×	463 2.8×	88	2.2k
G. Ruf Germany	14	1.1k 2.1×	82 0.2×	409 1.1×	639 1.9×	598 3.6×	45	2.6k
Rafael Alfonso‐Cristancho United States	20	336 0.6×	124 0.3×	182 0.5×	58 0.2×	90 0.5×	75	1.0k
Chris Farmer United Kingdom	23	330 0.6×	74 0.2×	125 0.3×	168 0.5×	540 3.2×	79	2.2k

Countries citing papers authored by E. Alemao

Since Specialization

Citations

This map shows the geographic impact of E. Alemao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Alemao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Alemao more than expected).

Fields of papers citing papers by E. Alemao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Alemao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Alemao. The network helps show where E. Alemao may publish in the future.

Co-authorship network of co-authors of E. Alemao

This figure shows the co-authorship network connecting the top 25 collaborators of E. Alemao. A scholar is included among the top collaborators of E. Alemao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Alemao. E. Alemao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wipfler, Kristin, et al.. (2023). POS0477 RELATIONSHIP BETWEEN SHARED EPITOPE STATUS AND REFRACTORY RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 82. 499–499. 1 indexed citations

Migliore, Alberto, et al.. (2021). Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211002682–1759720X211002682. 22 indexed citations

Marras, Theodore K., et al.. (2021). PIN33 How Does Mortality Differ In Early Vs. Late Diagnosed Nontuberculous Mycobacterial Lung Disease Among Patients With Chronic Obstructive Pulmonary Disease (COPD). Value in Health. 24. S111–S111. 3 indexed citations

Yun, Huifeng, Fenglong Xie, Lang Chen, et al.. (2020). Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry. The Journal of Rheumatology. 48(7). 992–1001. 7 indexed citations

George, Michael, Joshua F. Baker, Kevin Winthrop, et al.. (2020). Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery. Annals of the Rheumatic Diseases. 79(5). 573–580. 12 indexed citations

Beaumont, Jennifer L., et al.. (2019). Trajectories of health-related quality of life among renal transplant patients associated with graft failure and symptom distress: Analysis of the BENEFIT and BENEFIT-EXT trials. American Journal of Transplantation. 20(6). 1650–1658. 15 indexed citations

Feldman, Candace H., Kazuki Yoshida, Chang Xu, et al.. (2019). Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach. ACR Open Rheumatology. 1(9). 552–559. 10 indexed citations

Fleischmann, Roy, Michael E. Weinblatt, Michael A. Maldonado, et al.. (2019). Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE). Rheumatology and Therapy. 6(4). 559–571. 11 indexed citations

Alemao, E., Heather J. Litman, Seán Connolly, et al.. (2018). Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry. The Journal of Rheumatology. 45(10). 1353–1360. 2 indexed citations

10.

Alemao, E., Maiwenn Al, Matt Stevenson, et al.. (2018). Conceptual model for the health technology assessment of current and novel interventions in rheumatoid arthritis. PLoS ONE. 13(10). e0205013–e0205013. 9 indexed citations

11.

Harrold, Leslie R., Heather J. Litman, Seán Connolly, et al.. (2017). A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?. Clinical Rheumatology. 36(6). 1215–1220. 13 indexed citations

12.

Harrold, Leslie R., Heather J. Litman, Seán Connolly, et al.. (2017). Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study. The Journal of Rheumatology. 45(1). 32–39. 39 indexed citations

13.

Alemao, E., Zhenchao Guo, Michelle Frits, et al.. (2017). Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study. Seminars in Arthritis and Rheumatism. 47(5). 630–638. 16 indexed citations

14.

Furst, D E, Gerd R Burmester, Bernard Combe, et al.. (2014). Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 66. 2 indexed citations

15.

Alemao, E., et al.. (2008). Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes‐related complications. Diabetes Obesity and Metabolism. 10(s1). 33–42. 28 indexed citations

16.

Kohli, Michele, Cheryl Attard, Annette Lam, et al.. (2006). Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada. PharmacoEconomics. 24(8). 815–830. 18 indexed citations

17.

Alemao, E., et al.. (2006). Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland. American Journal of Cardiovascular Drugs. 6(5). 349–355. 15 indexed citations

18.

Goettsch, Wim, Donald Yin, E. Alemao, et al.. (2004). Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study;. Current Medical Research and Opinion. 20(7). 1025–1033. 27 indexed citations

19.

Bakhai, Ameet, Marcus Flather, J Collinson, et al.. (2003). National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. International Journal of Cardiology. 91(2-3). 163–172. 7 indexed citations

20.

Bousquet, Jean, Rami Ben‐Joseph, Mark L. Messonnier, E. Alemao, & A. Lawrence Gould. (2002). A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clinical Therapeutics. 24(1). 1–20. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact